本页面由Tiger Trade Technology Pte. Ltd.提供服务

Prometheus Biosciences, Inc.

199.92
0.0000
成交量:- -
成交额:3.72亿
市值:95.59亿
市盈率:-56.74
高:199.92
开:199.92
低:199.92
收:199.92
52周最高:199.98
52周最低:22.31
股本:4,781.22万
流通股本:3,323.34万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-3.5235
每股收益(LYR):-3.4899
净资产收益率:-33.30%
总资产收益率:-20.06%
市净率:13.70
市盈率(LYR):-57.28

数据加载中...

2023/06/16

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/06/16

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/06/16

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/06/16

重要事件披露

Form 8-K - Current report
2023/06/15

重要事件披露

Form 8-K - Current report
2023/05/23

重要事件披露

Form 8-K - Current report
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/28

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/04/17

重要事件披露

8-K - Current report
2023/03/10

重要事件披露

8-K - Current report
2023/03/08

关联方拟减持公告

144 - Report of proposed sale of securities
2023/03/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/28

重要事件披露

8-K - Current report
2023/02/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals